The contribution of red blood cells to thrombin generation in sickle cell disease: Meizothrombin generation on sickled red blood cells

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 12, 2013, Pages 2187-2189

  Whelihan, M F ^a   Mooberry, M J ^b   Zachary, V ^a   Bradford, R L ^b   Ataga, K I ^b   Mann, K G ^a   Key, N S ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; FIBRINOGEN; FLUORESCEIN ISOTHIOCYANATE; LACTADHERIN; MEIZOTHROMBIN; PHOSPHATIDYLSERINE; PROCOAGULANT; PROTHROMBIN; THROMBIN; TRYPSIN INHIBITOR;

ADULT; ANTICOAGULATION; BLOOD CLOTTING; CELL COUNT; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HEMATOCRIT; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOASSAY; LETTER; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SICKLE CELL ANEMIA; STEADY STATE; THROMBOCYTE;

ANEMIA, SICKLE CELL; ERYTHROCYTES; HUMANS; THROMBIN;

EID: 84889648423     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12423     Document Type: Letter

References (14)

1. Ballas SK, Smith ED. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 1992; 79: 2154-63.
2. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004; 11: 129-51.
3. Frenette PS. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol 2002; 9: 101-6.
4. Chiu D, Lubin B, Shohet SB. Erythrocyte membrane lipid reorganization during the sickling process. Br J Haematol 1979; 41: 223-34.
5. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32.
6. Setty BN, Rao AK, Stuart MJ. Thrombophilia in sickle cell disease: the red cell connection. Blood 2001; 98: 3228-33.
7. Whelihan MF, Zachary V, Orfeo T, Mann KG. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood 2012; 120: 3837-45.
8. Heldebrant CM, Butkowski RJ, Bajaj SP, Mann KG. The activation of prothrombin. II. Partial reactions, physical and chemical characterization of the intermediates of activation. J Biol Chem 1973; 248: 7149-63.
9. Krishnaswamy S, Church WR, Nesheim ME, Mann KG. Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem 1987; 262: 3291-9.
10. Haynes LM, Bouchard BA, Tracy PB, Mann KG. Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism. J Biol Chem 2012; 287: 38647-55.
11. Mann KG. Thrombin generation in hemorrhage control and vascular occlusion. Circulation 2011; 124: 225-35.
12. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996; 87: 1179-87.
13. Lim MY, Ataga KI, Key NS. Hemostatic abnormalities in sickle cell disease. Curr Opin Hematol 2013; 20: 472-7.
14. Doyle MF, Haley PE. Meizothrombin: active intermediate formed during prothrombinase-catalyzed activation of prothrombin. Methods Enzymol 1993; 222: 299-312.